Antibacterial properties and mode of action of a short acyl-lysyl oligomer

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3422-3429

  Zaknoon, Fadia ^a   Sarig, Hadar ^a   Rotem, Shahar ^a   Livne, Liran ^a   Ivankin, Andrey ^b   Gidalevitz, David ^b   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLLYSYL OLIGOMER; ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; EPIFLUORESCENCE MICROSCOPY; ESCHERICHIA COLI; GROWTH INHIBITION; HEMOLYSIS; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; STAPHYLOCOCCUS; SURFACE PLASMON RESONANCE;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; ERYTHROCYTES; ESCHERICHIA COLI; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MICROSCOPY, FLUORESCENCE; STAPHYLOCOCCUS; SURFACE PLASMON RESONANCE;

EID: 67749122303     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00010-09     Document Type: Article

References (60)

1. Anderson, V. R., and C. M. Perry. 2008. Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs 68:535-565.
2. Andreu, D., and L. Rivas. 1998. Animal antimicrobial peptides: an overview. Biopolymers 47:415-433.
3. Ben-Tal, N., B. Honig, R. M. Peitzsch, G. Denisov, and S. McLaughlin. 1996. Binding of small basic peptides to membranes containing acidic lipids: theoretical models and experimental results. Biophys. J. 71:561-575.
4. Blondelle, S. E., E. Takahashi, P. A. Weber, and R. A. Houghten. 1994. Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids. Antimicrob. Agents Chemother. 38:2280-2286.
5. Bohnert, J. A., and W. V. Kern. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849-852.
6. Boman, H. G., B. Agerberth, and A. Boman. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61:2978-2984.
7. Brickner, S. J., M. R. Barbachyn, D. K. Hutchinson, and P. R. Manninen. 2008. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. J. Med. Chem. 51:1981-1990.
8. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
9. Chongsiriwatana, N. P., J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. Ivankin, D. Gidalevitz, R. N. Zuckermann, and A. E. Barron. 2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA 105:2794-2799.
10. Couto, M. A., S. S. Harwig, and R. I. Lehrer. 1993. Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect. Immun. 61:2991-2994.
11. Crum, N. F., R. U. Lee, S. A. Thornton, O. C. Stine, M. R. Wallace, C. Barrozo, A. Keefer-Norris, S. Judd, and K. L. Russell. 2006. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am. J. Med. 119:943-951.
12. Cudic, M., and L. Otvos, Jr. 2002. Intracellular targets of antibacterial peptides. Curr. Drug Targets 3:101-106.
13. Dartois, V., J. Sanchez-Quesada, E. Cabezas, E. Chi, C. Dubbelde, C. Dunn, J. Granja, C. Gritzen, D. Weinberger, M. R. Ghadiri, and T. R. Parr, Jr. 2005. Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob. Agents Chemother. 49:3302-3310.
14. Epand, R. F., R. M. Epand, F. Formaggio, M. Crisma, H. Wu, R. I. Lehrer, and C. Toniolo. 2001. Analogs of the antimicrobial peptide trichogin having opposite membrane properties. Eur. J. Biochem. 268:703-712.
15. Epand, R. M., S. Rotem, A. Mor, B. Berno, and R. F. Epand. 2008. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 130:14346-14352.
16. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
17. Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry 42:12866-12874.
18. Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and M. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43:782-788.
19. Gibson, B. W., D. Z. Tang, R. Mandrell, M. Kelly, and E. R. Spindel. 1991. Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J. Biol. Chem. 266:23103-23111.
20. Gidalevitz, D., Y. Ishitsuka, A. S. Muresan, O. Konovalov, A. J. Waring, R. I. Lehrer, and K. Y. Lee. 2003. Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad. Sci. USA 100:6302-6307.
21. Gordon, Y. J., E. G. Romanowski, and A. M. McDermott. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 30:505-515.
22. Gracia, E., A. Fernandez, P. Conchello, J. L. Alabart, M. Perez, and B. Amorena. 1999. In vitro development of Staphylococcus aureus biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification. Luminescence 14:23-31.
23. Hancock, R. E., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.
24. Heller, W. T., A. J. Waring, R. I. Lehrer, and H. W. Huang. 1998. Multiple states of beta-sheet peptide protegrin in lipid bilayers. Biochemistry 37:17331-17338.
25. Ishitsuka, Y., L. Arnt, J. Majewski, S. Frey, M. Ratajczek, K. Kjaer, G. N. Tew, and K. Y. Lee. 2006. Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion. J. Am. Chem. Soc. 128:13123-13129.
26. Kamysz, W., C. Silvestri, O. Cirioni, A. Giacometti, A. Licci, V. A. Della, M. Okroj, and G. Scalise. 2007. In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. Antimicrob. Agents Chemother. 51:354-358.
27. Kavanagh, K., and S. Dowd. 2004. Histatins: antimicrobial peptides with therapeutic potential. J. Pharm. Pharmacol. 56:285-289.
28. Lohner, K., and E. J. Prenner. 1999. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1462:141-156.
29. Makovitzki, A., D. Avrahami, and Y. Shai. 2006. Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. USA 103:15997-16002.
30. Marynka, K., S. Rotem, I. Portnaya, U. Cogan, and A. Mor. 2007. In vitro discriminative antipseudomonal properties resulting from acyl substitution of N-terminal sequence of dermaseptin s4 derivatives. Chem. Biol. 14:75-85.
31. Midoux, P., R. Mayer, and M. Monsigny. 1995. Membrane permeabilization by alpha-helical peptides: a flow cytometry study. Biochim. Biophys. Acta 1239:249-256.
32. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
33. Navon-Venezia, S., R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694.
34. Neville, F., M. Cahuzac, O. Konovalov, Y. Ishitsuka, K. Y. Lee, I. Kuzmenko, G. M. Kale, and D. Gidalevitz. 2006. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys. J. 90:1275-1287.
35. Neville, F., C. S. Hodges, C. Liu, O. Konovalov, and D. Gidalevitz. 2006. In situ characterization of lipid A interaction with antimicrobial peptides using surface X-ray scattering. Biochim. Biophys. Acta 1758:232-240.
36. Neville, F. C., Y. Ishitsuka, C. S. Hodges, A. J. Waring, R. I. Lehrer, K. Y. C. Lee, and D. Gidalevitz. 2008. Protegrin interaction with lipid monolayers: grazing incidence X-ray diffraction and X-ray reflectivity study. Soft Matter 4:1665-1674.
37. Nishikata, M., T. Kanehira, H. Oh, H. Tani, M. Tazaki, and Y. Kuboki. 1991. Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. Biochem. Biophys. Res. Commun. 174:625-630.
38. Noto, M. J., P. M. Fox, and G. L. Archer. 2008. Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 52:1221-1229.
39. Oh, J. E., and K. H. Lee. 1999. Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide. Bioorg. Med. Chem. 7:2985-2990.
40. Patch, J. A., and A. E. Barron. 2002. Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers. Curr. Opin. Chem. Biol. 6:872-877.
41. Patrzykat, A., C. L. Friedrich, L. Zhang, V. Mendoza, and R. E. Hancock. 2002. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:605-614.
42. Radzishevsky, I., M. Krugliak, H. Ginsburg, and A. Mor. 2007. Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob. Agents Chemother. 51:1753-1759.
43. Radzishevsky, I. S., T. Kovachi, Y. Porat, L. Ziserman, F. Zaknoon, D. Danino, and A. Mor. 2008. Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol. 15:354-362.
44. Radzishevsky, I. S., S. Rotem, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25:657-659.
45. Rotem, S., and A. Mor. 2008. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta. doi10.1016/j.bbamem. 2008.10.020.
46. Rotem, S., I. S. Radzishevsky, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22:2652-2661.
47. Rydlo, T., S. Rotem, and A. Mor. 2006. Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother. 50:490-497.
48. Sarig, H., S. Rotem, L. Ziserman, D. Danino, and A. Mor. 2008. Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers. Antimicrob. Agents Chemother. 52:4308-4314.
49. Scott, R. W., W. F. Degrado, and G. N. Tew. 2008. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol. 19:620-627.
50. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
51. Simmaco, M., D. Barra, F. Chiarini, L. Noviello, P. Melchiorri, G. Kreil, and K. Richter. 1991. A family of bombinin-related peptides from the skin of Bombina variegata. Eur. J. Biochem. 199:217-222.
52. Som, A., S. Vemparala, I. Ivanov, and G. N. Tew. 2008. Synthetic mimics of antimicrobial peptides. Biopolymers 90:83-93.
53. Subbalakshmi, C., and N. Sitaram. 1998. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 160:91-96.
54. Tanford, C. 1980. The hydrophobic effect: formation of micelles and biological membranes. Wiley, New York, NY.
55. von Eiff, C., K. Becker, K. Machka, H. Stammer, G. Peters, et al. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
56. Wang, W., D. K. Smith, K. Moulding, and H. M. Chen. 1998. The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different composition. J. Biol. Chem. 273:27438-27448.
57. Weis, F., A. Beiras-Fernandez, and G. Schelling. 2008. Daptomycin, a lipopeptide antibiotic in clinical practice. Curr. Opin. Investig. Drugs 9:879-884.
58. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
59. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
60. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.